Flea is instructed by Autism Speaks

Flea has a rather amusing response to a letter about GI symptoms in autistic children that left him scratching his head...

Don't feel insulted, Flea; occasionally, we get mass mailings from cancer advocacy groups or--much more annoying to me and unfortunately much more frequent--pharmaceutical companies that sound as though they're telling us how to treat various cancers.

More like this

As pointed out by Dale in the comments over at Orac's post on Duesberg and aneuploidy, Duesberg and fellow HIV "dissident" David Rasnick are marketing a new cancer detection system, AnuCyte Cancer detection system, based upon his aneuploidy-basis-of-cancer ideas. And guess who else is on the…
I reported a few weeks ago that Ford had decided, despite considerable pressure from the religious right, to continue buying ads in gay-oriented publications. Now it seems that pressure has been turned up considerably. The Worldnutdaily has a report full of empty buzzwords and silliness: Leaders of…
The latest crankery from Adams is the evil male-chauvinist conspiracy to perpetuate breast cancer for fun and profit being led by none other than those dastardly villains of the American Cancer Society. With his stunning report and links to the thinkbeforeyoupink campaign, he rails against the…
This is a rather chilling story of academic freedom getting trampled. A whole pile of documentation is available at that link, I'll try to simplify it down a lot. UC Davis was sponsoring a public seminar on prostate cancer; specifically, they were actively promoting the prostate specific antigen (…

Thread hijack, but a relevant one with respect to "woo":

8756 Federal Register / Vol. 72, No. 38 / Tuesday, February 27, 2007 / Notices
http://a257.g.akamaitech.net/7/257/2422/01jan20071800/edocket.access.gp…

Draft Guidance for Industry on Complementary and Alternative Medicine Products and Their Regulation by the Food and Drug
Administration; Availability

ACTION: Notice.
SUMMARY: The Food and Drug Administration (FDA) is announcing the availability of a draft guidance for
industry entitled ''Complementary and Alternative Medicine Products and Their Regulation by the Food and Drug Administration.'' In recent years, the practice of complementary and alternative medicine (CAM) has
increased in the United States, and we have seen increased confusion as to whether certain products used in CAM are subject to regulation under the Federal Food, Drug, and Cosmetic Act (the act) or Public Health Service Act (PHS Act). We have also seen an increase in the number of CAM products imported into the United States. Therefore, the draft guidance discusses when a CAM product is subject to the act or the PHS Act. DATES: Submit written or electronic comments on the draft guidance by April 30, 2007.

My apologies if this was already spotted and posted here.